Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces blood loss and the need for blood transfusions during and after TURP surgery.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

New compounds may help treat prostate cancer by reducing cell growth.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Finasteride's effects on prostate cancer are not clear from this text.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Antioxidants can block the cancer-fighting effects of doxorubicin.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

The new method found new shared genetic areas linked to both Type 2 Diabetes and Prostate Cancer.

Finasteride safely lowers DHT levels without affecting hormone levels, helping with conditions like enlarged prostate, acne, and hair loss.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Ganoderma lucidum, a type of mushroom, may help treat enlarged prostate by blocking testosterone conversion.

Finasteride effectively treats baldness but may cause sexual side effects.

Dosing time affects finasteride's effectiveness and safety in rats.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Finasteride doesn't reduce sexual function in people with hair loss.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.